Cosmo and Glenmark receives market authorization for Winlevi in Europe EP News Bureau Nov 18, 2025 Cosmo Pharmaceuticals and Glenmark Pharmaceuticals, announced that the European Commission (EC) has granted Marketing…
Nezglyal remains promising therapy despite EMA’s market authorisation refusal: GlobalData EP News Bureau Feb 29, 2024 Nezglyal is a novel orally bioavailable and selective peroxisome proliferator-activated receptor (PPAR) gamma agonist that is…
